A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
Amgen
Kivu Bioscience Inc.
Amgen
BioNTech SE
Astellas Pharma Inc
AbbVie
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
MediLink Therapeutics (Suzhou) Co., Ltd.
Pfizer
Molecular Partners AG
Pfizer
Exscientia AI Limited
Seagen Inc.
Conjupro Biotherapeutics, Inc.
Bristol-Myers Squibb
Tempus AI
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
AstraZeneca
Radiopharm Theranostics, Ltd
AstraZeneca
Novartis
Avacta Life Sciences Ltd
Beijing Biotech
Zai Lab (Hong Kong), Ltd.
PMV Pharmaceuticals, Inc
Bristol-Myers Squibb
GlaxoSmithKline
BeOne Medicines
Akeso
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Neonc Technologies, Inc.
Daiichi Sankyo
Eli Lilly and Company
Abdera Therapeutics Inc.
Radiopharm Theranostics, Ltd
Tasca Therapeutics
Puma Biotechnology, Inc.
BioNTech SE
NiKang Therapeutics, Inc.
Boehringer Ingelheim
MacroGenics
Amgen
SystImmune Inc.
IDEAYA Biosciences
Jacobio Pharmaceuticals Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd